• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Vitrolife

95.75 SEK

-0.47 %

Less than 1K followers

VITR

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.47 %
-11.75 %
+1.86 %
-30.11 %
-30.92 %
-35.65 %
-55.34 %
-72.66 %
+1,460.21 %

Vitrolife is an international group that provides medical devices and genetic services. The company develops and manufactures services and products for personalized genetic information as well as medical devices in the field of fertility. Vitrolife supports customers in their operations to improve patient outcomes from fertility treatments. Vitrolife's products and services are available globally. The company is headquartered in Gothenburg, Sweden.

Read more
Market cap
12.97B SEK
Turnover
71.5M SEK
Revenue
3.44B
EBIT %
-140.55 %
P/E
-
Dividend yield-%
1.15 %
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
16.7
2026

Interim report Q2'26

22.10
2026

Interim report Q3'26

28.1
2027

Annual report '26

Press release6/1/2026, 10:00 AM

Vitrolife AB (publ): Vitrolife Group appoints Olivier Desmarets as Chief Operations Officer following Ermanno Sironi's retirement

Vitrolife
Regulatory press release5/22/2026, 10:00 AM

Vitrolife AB (publ): CEO Bronwyn Brophy O'Connor has decided to leave Vitrolife Group

Vitrolife
Regulatory press release5/5/2026, 4:30 PM

Report from the Annual General Meeting of Vitrolife AB (publ)

Vitrolife

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release4/24/2026, 7:41 AM

Redeye: Vitrolife (Q1 review): Fx-headwind but solid profitability

Vitrolife
Vitrolife, Audiocast, Q1'26
Webcast4/23/2026, 8:00 AM

Vitrolife, Audiocast, Q1'26

Vitrolife
Regulatory press release4/23/2026, 6:00 AM

Vitrolife AB (publ): Interim report Q1, 2026: Strong growth in Consumables and Technologies

Vitrolife
Press release4/9/2026, 7:00 AM

Vitrolife AB (publ): Invitation to Vitrolife Group's presentation of the Q1 2026 interim report

Vitrolife
Regulatory press release4/1/2026, 4:00 PM

Notice of the Annual General Meeting of Vitrolife AB (publ)

Vitrolife
Regulatory press release4/1/2026, 3:50 PM

Vitrolife AB (publ): The Nomination Committee proposes two new Board members

Vitrolife
Regulatory press release3/26/2026, 8:00 AM

Vitrolife AB (publ): Vitrolife Group has today published its Annual and Sustainability Report for 2025

Vitrolife
Press release2/4/2026, 8:24 AM

Redeye: Vitrolife (Q4 Review) - Excessive selloff improves risk/reward in the stock

Vitrolife
Vitrolife, Audiocast, Q4'25
Webcast2/3/2026, 9:00 AM

Vitrolife, Audiocast, Q4'25

Vitrolife
Regulatory press release2/3/2026, 7:00 AM

Vitrolife AB (publ): Fourth quarter and full year report 2025

Vitrolife
Press release1/20/2026, 4:36 PM

Vitrolife AB (publ): Invitation to Vitrolife Group's presentation of the fourth quarter and full year report 2025

Vitrolife
Press release12/22/2025, 12:05 PM

Redeye: Vitrolife - Updating our view on the case

Vitrolife
Regulatory press release12/16/2025, 6:02 PM

Vitrolife AB (publ): Vitrolife announces genetic services restructuring program targeting annualised savings of 65 MSEK and recognises a 5.4 BSEK goodwill impairment

Vitrolife
Press release10/29/2025, 8:00 AM

Nomination committee of Vitrolife AB (publ) for the Annual General Meeting 2026

Vitrolife
Vitrolife, Audiocast, Q3'25
Webcast10/23/2025, 8:00 AM

Vitrolife, Audiocast, Q3'25

Vitrolife
Regulatory press release10/23/2025, 6:00 AM

Vitrolife AB (publ): Interim report Q3, 2025: Strong growth in Americas

Vitrolife
Press release10/9/2025, 8:00 AM

Vitrolife AB (publ): Invitation to Vitrolife Group's presentation of the Q3 2025 interim report

Vitrolife